Huadong Medicine Co., Ltd (SHE:000963)
42.13
-0.25 (-0.59%)
At close: Dec 5, 2025
Huadong Medicine Revenue
Huadong Medicine had revenue of 10.99B CNY in the quarter ending September 30, 2025, with 4.53% growth. This brings the company's revenue in the last twelve months to 43.09B, up 3.32% year-over-year. In the year 2024, Huadong Medicine had annual revenue of 41.91B with 3.16% growth.
Revenue (ttm)
43.09B
Revenue Growth
+3.32%
P/S Ratio
1.71
Revenue / Employee
2.36M
Employees
18,265
Market Cap
73.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.91B | 1.28B | 3.16% |
| Dec 31, 2023 | 40.62B | 2.91B | 7.71% |
| Jan 1, 2023 | 37.71B | 3.15B | 9.12% |
| Jan 1, 2022 | 34.56B | 880.24M | 2.61% |
| Dec 31, 2020 | 33.68B | -1.76B | -4.97% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |